28036 Phase 2 randomized, placebo-controlled, dose-ranging study to evaluate the safety and efficacy of onabotulinumtoxina for the treatment of platysma prominence

Autor: Rohrich, Rodney, Bank, David E., Bertucci, Vince, Biesman, Brian S., Dayan, Steven, Humphrey, Shannon, Jones, Derek, Kaufman-Janette, Joely, Muhn, Channy Y., Rivers, Jason K., Tong, Warren
Zdroj: In Journal of the American Academy of Dermatology September 2021 85(3) Supplement:AB171-AB171
Databáze: ScienceDirect
Externí odkaz: